Background
==========

Methicillin-resistant Staphylococcus aureus (MRSA) has emerged worldwide as an important nosocomial pathogen since 1980s \[[@B1]\]. The transfer of colonized or infected patients between hospitals, and repeated hospital admissions were identified to be the two major causes of nosocomial MRSA acquisition \[[@B2],[@B3]\]. Other risk factors for hospital-acquired MRSA include antibiotic exposure, length of hospital stay, admission to intensive care unit (ICU), colonization pressure, and underlying co-morbidities. Hence, implementation of antimicrobial stewardship program, hand hygiene campaign, and the use of a bundle approach in the adult ICU were highly recommended for the effective control of nosocomial MRSA transmission \[[@B4]-[@B7]\].

In Hong Kong, the increasing number of elderly persons urged the need for long term institutional care and frequent hospitalizations. Long term care facilities (LTCFs) providing skilled nursery services for the elderlies in Hong Kong were found to be a major reservoir for MRSA. The prevalence of MRSA carriers among LTCF residents in Hong Kong was 2.8% to 5.1% in 2005 \[[@B8],[@B9]\]. Our recent study showed that 46% of patients with positive MRSA screening upon hospital admission were LTCF residents \[[@B10]\]. Other studies focusing on the prevalence and risk factors for MRSA colonization have also observed that a recent history of hospitalization is an important determinant for MRSA colonization among the population within LTCFs \[[@B8],[@B11]-[@B18]\]. However, the relative contribution of LTCFs and hospitals in the degree of MRSA transmission within the healthcare setting is undetermined.

In this study, we analyzed the acquisition of MRSA within LTCFs and hospitals in our locality. The findings of this study may have significant implication for infection control planning and resource allocation in the LTCFs.

Methods
=======

Study design
------------

This study compared (i) the prevalence and risk factors of MRSA colonization between the LTCFs and hospitals, and (ii) the incidence of MRSA transmission per 1000-colonization-days among the resident during their stay in LTCFs and hospitals. Furthermore, the transmission of MRSA was analyzed by Staphylococcus protein A (*spa*) typing, and the relationship between MRSA prevalence and living area per LTCF resident was also evaluated in this study.

Setting and participants
------------------------

A prospective study was conducted from 1 July to 31 December 2011 to determine the prevalence and acquisition of MRSA among LTCFs and their network hospitals in the Hong Kong West Cluster, which served a population of 0.53 million. LTCFs is a collective term for all long term nursing facilities that provide daily nursing care for their residents including the use of feeding tubes, urinary catheters and other medical devices. The hospital network in our healthcare region included a tertiary referral university-affiliated acute hospital with 1600 beds, 3 extended-care hospitals with a total of 1600 beds, and 1 pediatric hospital. Patients from LTCFs within our healthcare region are admitted to the acute hospital within the region for management. Once stabilized, patients would either be discharged to their original LTCFs or transferred to one of the 3 extended-care hospitals within the regional hospital network before returning to the LTCFs. Community geriatric assessment team, comprising of geriatricians, nurses and allied health professionals, would provide regular on-site visits to the LTCFs within our healthcare region for comprehensive medical follow-up and provide recommendations on infection control measures. In this study, we recruited all residents who agreed to join this study from the 57 LCTFs under the care of the community geriatric assessment team in our healthcare region. Also, we included nasal MRSA screening results of patients admitted to the acute hospital within the study period between 1 July and 31 December 2011 into the study for analysis.

This study protocol has been approved by the Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster (IRB reference number: UW 11--235).

Data collection
---------------

The objectives of the study and procedures involved were explained to the community geriatric assessment team and LTCFs representatives in our healthcare region. Informed consent was directly obtained from each of the participating residents, or their relatives if the resident was mentally incapacitated. Student nurses were recruited for specimen collection at the LTCFs and hospital admission wards between 1 July and 31 August 2011. They were trained by infection control nurses on the techniques in taking nasal swabs according to a standard protocol as previously described \[[@B19]\]. Patients' demographic information, history of hospitalization, underlying conditions, and the presence of indwelling devices, wounds or ulcers, were collected from patients' charts and hospital computer information system. Antimicrobial treatment history within the preceding three months of MRSA screening was also analyzed.

To obtain the number of MRSA carriers among the LTCF residents being hospitalized, MRSA screening from nasal swabs were taken within 24 hours when the the LTCF residents admitted to our acute hospital. Acquisition of MRSA in LTCFs was defined as a negative MRSA screening at the LTCFs between 1 July and 31 August 2011 followed by a positive result upon hospital admission screening. The time interval between the first negative sample collection at the LTCFs and the positive hospital admission screening was recorded. Similarly, to investigate the nosocomial MRSA acquisition among LTCF residents during their hospital stay, nasal swabs for MRSA screening were repeated at the acute and 3 extended-care hospitals before being discharged to the patients' respective LTCFs. Nosocomial acquisition of MRSA was defined as the conversion of nasal MRSA carriage status from negative to positive during hospitalization. The time interval between hospital admission and discharge was recorded.

The MRSA colonization pressure in different patient groups is estimated using the formula for calculating colonization pressures per 1000-LTCFs resident-days, as described previously \[[@B20]\]. The colonization pressure for LTCF residents was defined as the ratio of MRSA-carrying LTCF resident-days over the total number of LTCF resident-days, while the colonization pressure for hospitalized LTCF residents was defined as the ratio of imported-MRSA hospitalized-days over the total number of hospitalized days during the study. The incidence of MRSA transmission during their stay in LTCFs and in hospitals were measured in terms of MRSA transmission per 1000-colonization-days. The data on the total number of LTCFs resident-days and hospitalized days were collected from the community geriatric assessment team and the hospital record office respectively.

Data analysis
-------------

To determine the differences between patients with probable LTCF-acquired MRSA and probable hospital-acquired MRSA, patients were classified into "LTCFs subgroup" and "hospital subgroup" for further analysis. LTCF residents who had no history of hospitalization in the past 12 months are classified as 'LTCFs subgroup', while "hospital subgroup" consisted of non-LTCF patients who were admitted to the acute hospital within the study period. An exposure window of 12 months was selected as the length of monitoring period, since the median carriage of MRSA was found to be 8.5 months after hospital discharge \[[@B21]\], and the 12-months period has also been adopted in other MRSA transmission epidemiology studies \[[@B22],[@B23]\]. The risk factors for MRSA acquisition in the LTCFs subgroup were analyzed, and the MRSA *spa* type distribution between LTCFs and hospital subgroups were compared.

As the general demographic factors showed no significant difference on MRSA acquisition between the two subgroups, we sought for other potential LTCFs specific contributing factor. Hong Kong is a highly populated city with limited land resource and LTCFs are of great demand, therefore LTCFs are often crowded. Thus, we postulate that living area may affect the living standard of the elderly and the average living area in LTCFs may correlate with the hygienic standard of the LTCFs in Hong Kong. The overall MRSA prevalence in LTCFs was compared with the average living area (square feet per person) per resident of different LTCFs. The size of each LTCF was estimated from the government registrations and commercial websites for property trading and anonymous on-site assessment was made by two co-authors to validate the information. The official capacity and occupancy of each LTCF was collected from the community geriatric assessment team. The living area per person was defined as the total area of the LTCF divided by the number of residents at the time of study.

Microbiological analysis
------------------------

Swab specimens collected from the study subjects were delivered to the laboratory immediately for inoculation on MRSA chromID culture media (bioMérieux), which was incubated aerobically at 35°C for 48 hours. MRSA colonies were confirmed as previously described \[[@B19]\]. DNA was extracted from *S. aureus* colonies using alkaline lysis method and *spa* typing was performed on the first isolate from each person as previously described \[[@B9],[@B10],[@B24]\]. Repeat sequences were analyzed according to the Ribosomal Differentiation of Micro-organisms (RIDOM) database on *Staphylococcus aureus* (<http://www.ridom.de/staphtype>) for *spa* typing.

Statistical analysis
--------------------

For statistical calculation, the Chi-square test, Fisher's exact test, *t*-test, or the Mann--Whitney *U*-test was used where appropriate. Pearson correlation was calculated to evaluate the potential linear relationship between overall MRSA prevalence in the LTCFs and the average living area (square feet per person) per LTCF resident. All reported p-values were two-sided. A p-value of \<0.05 was considered statistically significant. Computation was performed using the Predictive Analytics Soft Ware (PASW) Version 18.0 (formerly SPSS) for Windows and R 2.14.0.

Results
=======

Prevalence and risk factors for MRSA colonization in LTCFs and hospitals
------------------------------------------------------------------------

Of the 57 LTCFs under the coverage of community geriatric assessment service at our healthcare region, 40 (70.2%) LTCFs participated in our study. The LTCF residents had to share toilet facilities. Nursing care was provided by on-site staff but the medical problems were taken care of by the community geriatric assessment team who visits at regular basis. Thirteen percent of residents have in situ feeding tubes, urinary catheters or other medical devices requiring special care. During the study period, 2900 residents lived in these LTCFs, of which 2020 residents (69.7%) consented for the study. Among the 2020 recruited residents, 436 of them (21.6%) were identified to be MRSA positive (Figure [1](#F1){ref-type="fig"}) through the LTCFs on-site surveillance screening. Compared with the other 1584 recruited residents without MRSA colonization, MRSA carriers had significantly more episodes of hospitalization (72.2% vs 53.7%, p \< 0.001) and longer cumulative length of hospital stay in the past 12 months (Additional file [1](#S1){ref-type="supplementary-material"}: Table S1).

![**Overview of the MRSA colonization among LTCF residents and hospitalized LTCF residents in the healthcare region, Hong Kong West.** Note. LTCFs, Long term care facilities.](1471-2334-13-205-1){#F1}

During the concurrent period, admission MRSA screening performed for all subjects in the study cohort within 24 hour of admission to the acute hospital. Among the patients from 1290 consecutive hospital admissions, 204 (15.8%) were identified as MRSA-positive (Figure [1](#F1){ref-type="fig"}). A significantly higher proportion of MRSA-positive patients were admitted directly from the LTCFs (57.4%) comparing to non-LTCF residents (13.6%) \[p \< 0.001; odd ratio of 8.52 (6.15-11.82)\] (Additional file [2](#S2){ref-type="supplementary-material"}: Table S2).

Eight hundred and fifty-four (42.3%) of 2020 LTCF residents with no history of hospitalization in the past 12 months (LTCFs subgroup) and 1025 (79.5%) of 1290 non-LTCF hospitalized patients (hospital subgroup) were selected for further analysis to determine the differences between patients with probable LTCF-acquired MRSA and probable hospital-acquired MRSA. From the LTCFs subgroup, 121 (14.2%) of 854 residents were MRSA carriers, while only 87 (8.5%) of 1025 patients from the hospital subgroup were identified as MRSA carriers (Figure [2](#F2){ref-type="fig"}). The risk factors for MRSA colonization in the LTCFs and hospital subgroups as determined by logistic regression analysis are shown in Table [1](#T1){ref-type="table"}. Residing in LTCFs was shown to be a significant risk factor for MRSA colonization. Moreover, the presence of urinary catheter, chronic cerebral conditions, the use of β-lactam/β-lactamase inhibitors within three months of MRSA screening were also found to be significant risk factors. After adjusting for the confounding factors, the estimated odds for persons having MRSA in LTCFs were 3.4 times higher than those not residing in LTCFs.

![Overview of the logistic of follow up analysis in both LTCF residents and hospitalized patients recruited in our study.](1471-2334-13-205-2){#F2}

###### 

Logistic regression analysis for the estimated probability of detection of MRSA with the following risk factors in the combined LTCFs subgroup and hospital subgroup

                                                                             **Estimate**   **Standard error**   **z value**   **p value**
  -------------------------------------------------------------------------- -------------- -------------------- ------------- -------------
  (Intercept)                                                                −3.257         0.189                −17.216       \<0.001
  Presence of nasogastric tube feeding                                       0.643          0.286                2.251         0.024
  Presence of urinary catheter                                               1.318          0.259                5.094         \<0.001
  Chronic cerebral conditions                                                0.794          0.187                4.247         \<0.001
  Use of β-lactam/β-lactamase inhibitors within 3 months of MRSA screening   0.860          0.224                3.843         \<0.001
  Residence in LTCFs                                                         1.218          0.205                5.945         \<0.001

LTCFs, long term care facilities.

Hospital subgroup, defined as patients who were not referred from LTCFs; LTCFs subgroup, defined as LTCF residents who had not been hospitalized in the past 12 months.

Note. After adjusting the other confounding factors, the estimated odds for persons having MRSA in LTCFs is exp (1.218) ≈ 3.4 times than those not residing in LTCFs.

Acquisition of MRSA among residents during their stay in LTCFs and in hospitals
-------------------------------------------------------------------------------

Among the 1584 LTCF residents who were found to be non-MRSA carriers during the on-site surveillance period between 1 July and 31 August 2011, 337 of them (21.3%) were subsequently admitted to the acute hospitals, and were subjected to MRSA admission and discharge screening (Figure [1](#F1){ref-type="fig"}). Admission screening had identified 65/337 (19.3%) residents to have become MRSA-positive suggesting that they had acquired MRSA in the LTCFs since the time of on-site surveillance. The median time of MRSA detection from surveillance to admission was 77 days (range, 9--181 days). Given that the 436 MRSA-positive residents identified during the on-site surveillance had stayed in the 40 LTCFs for 66,802 days, and the overall 2020 residents had stayed in the LTCFs for 317,752 days during our study period, the colonization pressure of MRSA in LTCFs would be 210 per 1000-resident-days \[(MRSA resident-days of 436 MRSA-positive residents was 66,802 days)/(total resident-days of 2020 residents was 317,752 days) × 1000 days\]. With the use of these information, the rate of MRSA transmission of the 65 defined LTCFs acquired MRSA was estimated to be 309 MRSA transmissions per 1000-colonization-days among LTCF residents \[(65 residents acquired MRSA in LTCFs)/(colonization pressure of 210 per 1000-resident-days) × 1000 days\].

During hospitalization, 21 (7.7%) out of 272 the MRSA-negative LTCF residents acquired MRSA. The median time of MRSA detection was 7 days (ranged 1--31 days). Given that the 65 LTCF-acquired MRSA residents stayed in hospital for a total of 396 days, and the 337 non-MRSA carrying LTCF residents, during the on-site surveillance, stayed for 2137 days during our study period, the MRSA colonization pressure for hospitalized LTCF residents was 185 per 1000-patient-days \[(imported-MRSA patient-days of 396 days)/(total patient-days of 337 residents of 2137 days) × 1000 days\]. Based on this data, we further estimated the rate of MRSA transmission for hospitalized LTCF residents to be 113 MRSA transmissions per 1000-colonization-days \[(21 residents acquired MRSA in hospital)/(colonization pressure of 185 per 1000-patient-days) × 1000 days\]. The demographic characteristics of persons with MRSA acquisition in LTCFs and hospitals were not significantly difference (Table [2](#T2){ref-type="table"}).

###### 

Demographic characteristics of LTCF residents with MRSA acquisition in LTCFs and hospitals

                                                          **MRSA acquisition in LTCFs (n = 65)**   **MRSA acquisition in hospitals (n = 21)**   **p value**
  ------------------------------------------------------- ---------------------------------------- -------------------------------------------- -------------
  Age (mean ± SD)                                         85.1 ± 10.2                              84.2 ± 10.8                                  0.744
  Sex (male)                                              24 (36.9%)                               8 (38.1%)                                    0.923
  Underlying diseases                                                                                                                            
    Chronic cerebral conditions ^a^                       29 (44.6%)                               7 (33.3%)                                    0.362
    Chronic cardiac conditions ^b^                        8 (12.3%)                                6 (28.6%)                                    0.079
    Chronic pulmonary conditions ^c^                      7 (10.8%)                                3 (14.3%)                                    0.662
    Chronic renal failure                                 2 (3.1%)                                 2 (9.5%)                                     0.223
    Liver cirrhosis                                       0                                        0                                            NA
    Diabetes mellitus                                     11 (16.9%)                               5 (23.8%)                                    0.481
    Malignancy                                            4 (6.2%)                                 1 (4.8%)                                     0.813
  Presence of                                                                                                                                    
    Nasogastric tube                                      23 (35.4%)                               7 (33.3%)                                    0.864
    Urinary catheter                                      15 (23.1%)                               3 (14.3%)                                    0.389
    Tenckhoff catheter                                    0                                        0                                            NA
    Wound or ulcer                                        1 (1.5%)                                 2 (9.5%)                                     0.083
  Antibiotics therapy within 3 months of MRSA screening                                                                                          
    Penicillin group                                      11 (16.9%)                               6 (28.6%)                                    0.244
    β-lactam/β-lactamase inhibitors                       23 (35.4%)                               8 (38.1%)                                    0.822
    Cephalosporin group                                   7 (10.8%)                                3 (14.3%)                                    0.662
    Carbapenem group                                      0                                        1 (4.8%)                                     0.077
    Fluoroquinolones                                      2 (3.1%)                                 2 (9.5%)                                     0.223

LTCFs, residential care homes for elderly; MRSA, methicillin-resistant *Staphylococcus aureus*; NA, not applicable; ^a^ chronic cerebral conditions included cerebrovascular accident, dementia, and Parkinson disease; ^b^ chronic cardiac conditions included ischemic heart disease and congestive heart failure; ^c^ chronic pulmonary conditions included chronic bronchitis, chronic obstructive pulmonary disease, and asthma.

Relationship between MRSA prevalence and living area per LTCFs resident
-----------------------------------------------------------------------

An inverse linear relationship between MRSA prevalence in the LTCFs and average living area (square feet per person) per LTCF resident was found (Figure [3](#F3){ref-type="fig"}). Pearson correlation of MRSA prevalence per LTCF and living area per resident was −0.443 (p = 0.004). Risk factors for MRSA colonization in the LTCFs subgroup was shown in Table [3](#T3){ref-type="table"}. The odds of patients having MRSA reduced by a factor of 0.90 for each 10 square feet increase in area per person when the other risk factors were held constant (Table [4](#T4){ref-type="table"}).

![**The relationship between the MRSA prevalence per LTCF and the average living area (square feet per person) per LTCF resident.** Note. Pearson correlation of MRSA prevalence per LTCFs and area (square feet) per person = −0.443 (p = 0.004).](1471-2334-13-205-3){#F3}

###### 

Risk factors for MRSA colonization in the LTCFs subgroup

                                                          **MRSA carrier (n = 121)**   **Non-MRSA carrier (n = 733)**   **p value**
  ------------------------------------------------------- ---------------------------- -------------------------------- -------------
  Age (mean ± SD)                                         84.3 ± 8.9                   83.0 ± 10.1                      0.144
  Sex (male)                                              35 (28.9%)                   246 (33.6%)                      0.368
  Underlying diseases                                                                                                    
  Chronic cerebral conditions ^a^                         25 (20.7%)                   84 (11.5%)                       0.008
  Presence of                                                                                                            
  Nasogastric tube                                        13 (10.7%)                   39 (5.3%)                        0.035
  Urinary catheter                                        5 (4.1%)                     5 (0.7%)                         0.005
  Antibiotics therapy within 3 months of MRSA screening                                                                  
  β -lactam/β-lactamase inhibitors                        6 (5.0%)                     15 (2.0%)                        0.110
  Area (square feet) per person ^b^                       108.8 ± 20.1                 113.0 ± 19.0                     0.031

LTCFs, long term care facilities; LTCFs subgroup, defined as LTCF residents who had not been hospitalized in the past 12 months; SD, standard deviation; ^a^ chronic cerebral conditions included cerebrovascular accident, dementia, and Parkinson disease; ^b^ area per person is defined as total area of the LTCFs over the number of resident occupying at the time of study.

###### 

Logistic regression analysis for the estimated probability of detection of MRSA with the following risk factors in the LTCFs subgroup

                                      **Estimate**   **Standard error**   **z value**   **p value**
  ----------------------------------- -------------- -------------------- ------------- -------------
  (Intercept)                         −0.422         0.578                −0.729        0.46588
  Presence of urinary catheter        2.125          0.660                3.219         0.00129
  Chronic cerebral conditions         0.742          0.256                2.899         0.00374
  Area (square feet) per person ^a^   −0.014         0.006                −2.648        0.0081

LTCFs, long term care facilities; LTCFs subgroup, defined as LTCF residents who had not been hospitalized in the past 12 months; ^a^ area per person is defined as total area of the LTCFs over the number of resident occupying at the time of study.

Note. The odds of a patient having MRSA decreased by exp (−0.14) ≈ 0.90 times with each 10 square feet increase in area (square feet) per person when the other risk factors of presence of urinary catheter and chronic cerebral conditions were held constant.

Spa type diversity in LTCFs subgroup and hospital subgroup
----------------------------------------------------------

*Spa* typing was performed for 121 MRSA strains from the LTCFs subgroup and 87 MRSA strains from the hospital subgroup. The *spa* type diversities were significantly different between the two subgroups (Fisher's exact test, p \<0.01) (Table [5](#T5){ref-type="table"}). The most common *spa* type was t1081, which constituted 76 (62.8%) of 121 and 51 (58.6%) of 87 MRSA strains from the LTCFs and hospital subgroups respectively. Another *spa* type t4677 was significantly associated with the LTCFs subgroup while t002 was significantly associated with the hospital subgroup. This diversity in *spa* type was also observed among the 337 patients who were MRSA-negative during LTCFs on-site surveillance who were subsequently hospitalized within the study period. The 65 patients (65/337, 19.3%) who were identified to be positive with MRSA at the admission screening had *spa* types which belonged to the LTCFs subgroup, while the 272 (272/337, 80.7%) who were MRSA-negative at admission screening but later became MRSA-positive at discharge screening had *spa* types which belonged to the hospital subgroup.

###### 

**Comparison of MRSA*spa*type in the LTCFs subgroup and hospital subgroup**

  **Spa type**   **MRSA in LTCFs subgroup**   **MRSA in hospital subgroup**   **p value**   **Odd ratio**
  -------------- ---------------------------- ------------------------------- ------------- ---------------
  t002           2 (1.7%)                     14 (16.1%)                      \<0.001       0.09
  t032           2 (1.7%)                     5 (5.7%)                        0.132         0.28
  t037           2 (1.7%)                     6 (6.9%)                        0.070         0.23
  t701           8 (6.6%)                     1 (1.1%)                        0.083         6.05
  t1081          76 (62.8%)                   51 (58.6%)                      0.567         1.19
  t4677          24 (19.8%)                   3 (3.4%)                        \<0.001       6.88
  Other          7 (5.8%) ^a^                 7 (8.0%) ^b^                    NA            NA
  Total          121 (100%)                   87 (100%)                       NA            NA

Hospital subgroup, defined as hospitalized patients who were not referred from LTCFs; NA, not applicable; LTCFs, long term care facilities; LTCFs subgroup, defined as LTCF residents who had not been hospitalized in the past 12 months; ^a^ including *spa* types of t121 (2), t012 (1), t1026 (1), t1765 (1), t2536 (1), and t588 (1); ^b^ including spa types of t437 (2), t1250 (1), t1751 (1), t441 (1), t5413 (1), and t9377 (1).

Discussion
==========

Our study showed that the prevalence of MRSA among LTCFs in Hong Kong had increased substantially from 3-5% to over 20% (436 MRSA positive/2020 residents in 40 LTCFs) (Figure [1](#F1){ref-type="fig"}) in the recent six years \[[@B8],[@B9]\]. This finding is comparable to those in the United States \[[@B25]\] study but higher than other studies conducted in Germany \[[@B11],[@B18]\], Belgium \[[@B12],[@B16]\], and Spain \[[@B15]\]. Similar to the previous studies, history of hospitalization, chronic comorbidity, indwelling devices, wound or ulcer, and antimicrobial therapy were found to be risk factors for MRSA colonization in our study \[[@B11],[@B12],[@B15],[@B16],[@B18]\]. Moreover, residence in LTCFs and a long cumulative length of hospital stay in the past 12 months were again found to be significant risk factors for MRSA colonization by univariate analysis in our concurrent admission screening \[[@B26]-[@B30]\]. Transfer of patients between LTCFs and hospitals creates a vicious cycle which perpetuates MRSA transmission. Hence, it is of great importance to investigate the relative contribution of LTCFs and hospitals in the transmission dynamics of MRSA in the healthcare setting.

Through this study, we identified that acquisition of MRSA among LTCF residents was 3.4 times higher than those patients who did not reside in LTCFs by multivariate analysis. The incidence of MRSA transmission per 1000-colonization-days among LTCF residents was also three times higher than that of the hospitalized LTCF residents, given that the colonization pressure in both LTCFs and hospital were similar. Our findings suggested that MRSA transmission in LTCFs was more severe than that in the hospitals.

While there was no difference in risk factors between patients with LTCFs-acquired and hospital-acquired MRSA, it was noted that the average living area per resident in different LTCFs was an important surrogate marker reflecting the hygienic standard of LTCFs. An inverse linear relationship between MRSA prevalence in the LTCFs and the average living area per resident was found. Provided that the other risk factors were held constant, the odds of patients acquiring MRSA is reduced by a factor of 0.9 for each increment of 10 square feet in living area. To our best knowledge, our study is the first quantitative analysis to demonstrate that living area per person could be a determinant of MRSA prevalence in LTCFs. This finding is particularly relevant for urban cities with a high population density like Hong Kong with an average land price of USD 1000 per square feet. The supply of residential land is limited and living environments are characterized by extremely compact multi-storey apartments \[[@B31]\]. The average living area is an important indicator of the degree of spatial separation, making it a suitable surrogate marker of LTCFs in terms of the overall standard of care, hygiene and infection control. Indeed, overcrowded environment in the correctional facility had been implicated as a contributing factor for MRSA transmission in the United States \[[@B32],[@B33]\].

The *spa* typing results of MRSA strains collected from the LTCFs and hospital subgroups showed that two distinct *spa* type linages, t4677 and t002, were significantly associated with the LTCFs subgroup and the hospital subgroup respectively. Type t002 was commonly found in hospitalized patients in our region and the United States \[[@B10],[@B34],[@B35]\] whereas type t4677 had not been reported in the community or hospital setting previously. This might suggest that t4677 isolates circulated exclusively among LTCF residents in our locality. On the other hand, the high predominance of type t1081 (about 60% of isolates) in both the LTCFs and hospital subgroups could be explained by the intrinsically high transmissibility of t1081 as shown in our previous study \[[@B10]\]. Alternatively, t1081 might have been introduced into our healthcare system in the early years allowing cross-transmission among LTCF residents and hospitalized patients. In fact, t1081 had been predominantly found in our LTCFs in 2005 \[[@B9]\], and t1081, as a member of ST45/Staphylococcus cassette chromosome mec (*SCC*mec) IV or V, was increasingly reported in our hospital isolates from 1995 to 2005 \[[@B36]\].

There are several limitations in our study. Firstly, only 70% of the LTCF residents consented for this study introducing potential bias in subject selection. In addition, we only collected nasal specimens for MRSA screening due to resource limitation. Furthermore, the sensitivity of detection \[[@B37]\] may be compromised in subjects with low microbial load while not on antibiotic therapy \[[@B19],[@B38]\]. Chromogenic agar, however, was used to improve sensitivity and cost-effectiveness \[[@B39]\]. We did not analyze the staffing ratio in LTCFs, which might affect the prevalence of MRSA \[[@B40]\]. As the LTCFs have to satisfy the basic infection control measures required by the government, living area per resident was chosen as an important surrogate marker reflecting the hygienic standard of LTCFs. We did not screen for MRSA carriage among healthcare workers in the LTCFs and hospitals since the benefit of carriage eradication is not established in non-outbreak setting \[[@B41]\], despite a recent study suggesting that both residents and staff were involved in MRSA transmissions \[[@B42]\]. In addition, this is a single season study and may not be applicable to other seasons.

Conclusion
==========

In summary, we had established the relative importance of LTCFs in the transmission dynamics of MRSA between LTCFs and hospitals in the healthcare setting. More resources should be allocated to improve the infection control measures of LTCFs and further studies are necessary to understand key factors, such as space availability, that lead to high level of MRSA transmission within LTCFs.
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